Owens & Minor (NYSE:OMI - Get Free Report) will be issuing its quarterly earnings data before the market opens on Monday, November 4th. Analysts expect the company to announce earnings of $0.40 per share for the quarter. Owens & Minor has set its FY24 guidance at $1.40-1.70 EPS.Parties interested in registering for the company's conference call can do so using this link.
Owens & Minor (NYSE:OMI - Get Free Report) last announced its earnings results on Friday, August 2nd. The company reported $0.36 EPS for the quarter, beating analysts' consensus estimates of $0.33 by $0.03. Owens & Minor had a positive return on equity of 14.66% and a negative net margin of 0.40%. The business had revenue of $2.67 billion during the quarter, compared to analysts' expectations of $2.65 billion. During the same quarter in the prior year, the firm earned $0.18 earnings per share. The business's revenue was up 4.2% compared to the same quarter last year. On average, analysts expect Owens & Minor to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Owens & Minor Stock Performance
Shares of Owens & Minor stock traded down $0.10 during mid-day trading on Monday, reaching $13.31. 747,340 shares of the stock traded hands, compared to its average volume of 824,417. The business has a 50-day moving average of $14.90 and a 200 day moving average of $16.70. Owens & Minor has a fifty-two week low of $12.36 and a fifty-two week high of $28.35. The company has a debt-to-equity ratio of 2.17, a current ratio of 1.09 and a quick ratio of 0.51.
Analyst Ratings Changes
Several brokerages recently weighed in on OMI. Citigroup upgraded Owens & Minor from a "neutral" rating to a "buy" rating and lowered their price objective for the stock from $24.00 to $19.00 in a research report on Friday, July 19th. Robert W. Baird lowered their price objective on Owens & Minor from $20.00 to $19.00 and set a "neutral" rating for the company in a research report on Tuesday, July 16th. Barclays lowered their price objective on Owens & Minor from $23.00 to $18.00 and set an "equal weight" rating for the company in a research report on Monday, August 5th. JPMorgan Chase & Co. lowered their price objective on Owens & Minor from $22.00 to $18.00 and set an "underweight" rating for the company in a research report on Wednesday, August 21st. Finally, StockNews.com lowered Owens & Minor from a "buy" rating to a "hold" rating in a research report on Monday, August 26th. Two analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat.com, Owens & Minor presently has an average rating of "Hold" and a consensus price target of $20.00.
Get Our Latest Research Report on Owens & Minor
About Owens & Minor
(
Get Free Report)
Owens & Minor, Inc, together with its subsidiaries, operates as a healthcare solutions company worldwide. It operates through Products & Healthcare Services and Patient Direct segments. The Products & Healthcare Services segment offers a portfolio of products and services to healthcare providers and manufacturers.
Further Reading
Before you consider Owens & Minor, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Owens & Minor wasn't on the list.
While Owens & Minor currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
